Trial Outcomes & Findings for Normal Breathing and Swallowing in Healthy Volunteers (NCT NCT03122145)

NCT ID: NCT03122145

Last Updated: 2021-01-14

Results Overview

Reflexive cough testing will use a capsaicin challenge that will assess individual's cough motor and cough sensory thresholds. A modified Borg scale ranging from 0 (no cough) to 10 (maximal urge to cough) will be used to quantify these thresholds. A cough sensory threshold will be defined as a concentration of capsaicin eliciting a perceived urge to cough of 1 (very slight) \>2/3 trials. A cough motor threshold will be the lowest concentration of capsaicin eliciting \>2 cough responses in 2/3 trials.

Recruitment status

COMPLETED

Study phase

PHASE1/PHASE2

Target enrollment

49 participants

Primary outcome timeframe

Single assessment time period

Results posted on

2021-01-14

Participant Flow

2018-2019 HealthStreet university approved flyers

Experiment #1: single 60 minute visit with multiple assessments of cough and respiratory function. Experiment #2: single 60-minute visit with an instrumental swallowing evaluation (videofluoroscopy).

Participant milestones

Participant milestones
Measure
Healthy Volunteers - Experiment #1
This study will involve a single 60-minute visit where healthy, eligible participants will then undergo testing to determine their individualized voluntary and reflexive cough testing. The participant will be free to leave at any point during the examination. Capsaicin: Participants will inspire deeply through the nebulizer coupled to the facemask and pneumotachograph. Each test inhalation will be separated by an interval of 2 minutes. This experimental trial consists of six test solutions: 0, 25, 50, 100, 200 and 500 μM capsaicin in 80% physiological saline, 20% ethanol. Participants will inhale single vital capacity breaths of capsaicin solution via an air-powered dosimeter (KoKoDigidoser).
Healthy Volunteers - Experiment #2
This study will involve a single 60-minute visit eligible participants will then undergo an instrumental swallowing evaluation (videofluoroscopy). All women under the age of 62 will be asked to complete a pregnancy test as part of the screening process prior to radiation exposure. The entire duration of the exam will be under 60 minutes and the participant will be free to leave at any point during the examination.
Overall Study
STARTED
37
12
Overall Study
COMPLETED
34
12
Overall Study
NOT COMPLETED
3
0

Reasons for withdrawal

Reasons for withdrawal
Measure
Healthy Volunteers - Experiment #1
This study will involve a single 60-minute visit where healthy, eligible participants will then undergo testing to determine their individualized voluntary and reflexive cough testing. The participant will be free to leave at any point during the examination. Capsaicin: Participants will inspire deeply through the nebulizer coupled to the facemask and pneumotachograph. Each test inhalation will be separated by an interval of 2 minutes. This experimental trial consists of six test solutions: 0, 25, 50, 100, 200 and 500 μM capsaicin in 80% physiological saline, 20% ethanol. Participants will inhale single vital capacity breaths of capsaicin solution via an air-powered dosimeter (KoKoDigidoser).
Healthy Volunteers - Experiment #2
This study will involve a single 60-minute visit eligible participants will then undergo an instrumental swallowing evaluation (videofluoroscopy). All women under the age of 62 will be asked to complete a pregnancy test as part of the screening process prior to radiation exposure. The entire duration of the exam will be under 60 minutes and the participant will be free to leave at any point during the examination.
Overall Study
Concurrent respiratory disease
3
0

Baseline Characteristics

Normal Breathing and Swallowing in Healthy Volunteers

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Healthy Volunteers - Experiment #1
n=34 Participants
This study will involve a single 60-minute visit where healthy, eligible participants will undergo testing to determine their individualized voluntary and reflexive cough testing. The participant will be free to leave at any point during the examination.
Healthy Volunteers - Experiment #2
n=12 Participants
This study will involve a single 60-minute visit where healthy, eligible participants will undergo an instrumental swallowing evaluation (videofluoroscopy). All women under the age of 62 will be asked to complete a pregnancy test as part of the screening process during to radiation exposure. The participant will be free to leave at any point during the examination.
Total
n=46 Participants
Total of all reporting groups
Age, Categorical
<=18 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Age, Categorical
Between 18 and 65 years
18 Participants
n=5 Participants
12 Participants
n=7 Participants
30 Participants
n=5 Participants
Age, Categorical
>=65 years
16 Participants
n=5 Participants
0 Participants
n=7 Participants
16 Participants
n=5 Participants
Age, Continuous
60.9 years
STANDARD_DEVIATION 15.22 • n=5 Participants
27 years
STANDARD_DEVIATION 3.86 • n=7 Participants
52 years
STANDARD_DEVIATION 18.44 • n=5 Participants
Sex: Female, Male
Female
20 Participants
n=5 Participants
10 Participants
n=7 Participants
30 Participants
n=5 Participants
Sex: Female, Male
Male
14 Participants
n=5 Participants
2 Participants
n=7 Participants
16 Participants
n=5 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Asian
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Black or African American
2 Participants
n=5 Participants
0 Participants
n=7 Participants
2 Participants
n=5 Participants
Race (NIH/OMB)
White
25 Participants
n=5 Participants
0 Participants
n=7 Participants
25 Participants
n=5 Participants
Race (NIH/OMB)
More than one race
5 Participants
n=5 Participants
0 Participants
n=7 Participants
5 Participants
n=5 Participants
Race (NIH/OMB)
Unknown or Not Reported
2 Participants
n=5 Participants
12 Participants
n=7 Participants
14 Participants
n=5 Participants
Region of Enrollment
United States
34 Participants
n=5 Participants
12 Participants
n=7 Participants
46 Participants
n=5 Participants

PRIMARY outcome

Timeframe: Single assessment time period

Population: Participants who completed the entire randomized reflex cough testing protocol were included in the analysis

Reflexive cough testing will use a capsaicin challenge that will assess individual's cough motor and cough sensory thresholds. A modified Borg scale ranging from 0 (no cough) to 10 (maximal urge to cough) will be used to quantify these thresholds. A cough sensory threshold will be defined as a concentration of capsaicin eliciting a perceived urge to cough of 1 (very slight) \>2/3 trials. A cough motor threshold will be the lowest concentration of capsaicin eliciting \>2 cough responses in 2/3 trials.

Outcome measures

Outcome measures
Measure
Healthy Volunteers
n=34 Participants
This study will involve a single 90-minute visit. All women under the age of 62 will be asked to complete a pregnancy test as part of the screening process during to radiation exposure. Eligible participants will then undergo voluntary and reflexive cough testing, tongue pressure testing and a comprehensive instrumental swallowing evaluation. The entire duration of the exam will be under 90 minutes and the participant will be free to leave at any point during the examination. Capsaicin: Participants will inspire deeply through the nebulizer coupled to the facemask and pneumotachograph. Each test inhalation will be separated by an interval of 2 minutes. This experimental trial consists of six (instead of 8) test solutions: 0, 25, 50, 100, 200 and 500 μM capsaicin in
Reflexive Cough Testing (With Urge-to-Cough)
cough motor threshold
3 units on a scale
Interval 0.0 to 10.0
Reflexive Cough Testing (With Urge-to-Cough)
cough sensory threshold
5 units on a scale
Interval 0.5 to 10.0

PRIMARY outcome

Timeframe: Single Visit

LVC temporal measures will be used to calculate the duration of laryngeal vestibule closure (dLVC)

Outcome measures

Outcome measures
Measure
Healthy Volunteers
n=12 Participants
This study will involve a single 90-minute visit. All women under the age of 62 will be asked to complete a pregnancy test as part of the screening process during to radiation exposure. Eligible participants will then undergo voluntary and reflexive cough testing, tongue pressure testing and a comprehensive instrumental swallowing evaluation. The entire duration of the exam will be under 90 minutes and the participant will be free to leave at any point during the examination. Capsaicin: Participants will inspire deeply through the nebulizer coupled to the facemask and pneumotachograph. Each test inhalation will be separated by an interval of 2 minutes. This experimental trial consists of six (instead of 8) test solutions: 0, 25, 50, 100, 200 and 500 μM capsaicin in
Duration of Laryngeal Vestibule Closure (dLVC)
5 swallows with head in chin up position
435 Milliseconds
Standard Deviation 41
Duration of Laryngeal Vestibule Closure (dLVC)
5 swallows with e-stim to anterior neck
429 Milliseconds
Standard Deviation 61
Duration of Laryngeal Vestibule Closure (dLVC)
5 swallows with head in neutral position
461 Milliseconds
Standard Deviation 39

PRIMARY outcome

Timeframe: Single Visit

LVC temporal measures will be used to calculate the laryngeal vestibule closure reaction time (LVCrt)

Outcome measures

Outcome measures
Measure
Healthy Volunteers
n=12 Participants
This study will involve a single 90-minute visit. All women under the age of 62 will be asked to complete a pregnancy test as part of the screening process during to radiation exposure. Eligible participants will then undergo voluntary and reflexive cough testing, tongue pressure testing and a comprehensive instrumental swallowing evaluation. The entire duration of the exam will be under 90 minutes and the participant will be free to leave at any point during the examination. Capsaicin: Participants will inspire deeply through the nebulizer coupled to the facemask and pneumotachograph. Each test inhalation will be separated by an interval of 2 minutes. This experimental trial consists of six (instead of 8) test solutions: 0, 25, 50, 100, 200 and 500 μM capsaicin in
Laryngeal Vestibule Closure Reaction Time (LVCrt)
5 swallows with head in chin up position
181 Milliseconds
Standard Deviation 31
Laryngeal Vestibule Closure Reaction Time (LVCrt)
5 swallows with e-stim to anterior neck
174 Milliseconds
Standard Deviation 23
Laryngeal Vestibule Closure Reaction Time (LVCrt)
5 swallows with head in neutral position
169 Milliseconds
Standard Deviation 34

SECONDARY outcome

Timeframe: Baseline

Population: Participants who completed the voluntary cough testing protocol in its entirety were included in the analysis

Voluntary peak cough flow testing will be used to capture the volume of air expelled in the 1st second of cough as measured in PEF and FEV1.

Outcome measures

Outcome measures
Measure
Healthy Volunteers
n=34 Participants
This study will involve a single 90-minute visit. All women under the age of 62 will be asked to complete a pregnancy test as part of the screening process during to radiation exposure. Eligible participants will then undergo voluntary and reflexive cough testing, tongue pressure testing and a comprehensive instrumental swallowing evaluation. The entire duration of the exam will be under 90 minutes and the participant will be free to leave at any point during the examination. Capsaicin: Participants will inspire deeply through the nebulizer coupled to the facemask and pneumotachograph. Each test inhalation will be separated by an interval of 2 minutes. This experimental trial consists of six (instead of 8) test solutions: 0, 25, 50, 100, 200 and 500 μM capsaicin in
Voluntary Peak Cough Flow Testing (With Electronic Peak Cough Flow Meter Device)
3.15 liters per second
Standard Deviation 1.01

Adverse Events

Healthy Volunteers - Experiment #1

Serious events: 0 serious events
Other events: 1 other events
Deaths: 0 deaths

Healthy Volunteers - Experiment #2

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Other adverse events
Measure
Healthy Volunteers - Experiment #1
n=34 participants at risk
This study will involve a single 60-minute visit where healthy, eligible participants will undergo voluntary and reflexive cough testing. Capsaicin: Participants will inspire deeply through the nebulizer coupled to the facemask and pneumotachograph. Each test inhalation will be separated by an interval of 2 minutes. This experimental trial consists of six (instead of 8) test solutions: 0, 25, 50, 100, 200 and 500 μM capsaicin
Healthy Volunteers - Experiment #2
n=12 participants at risk
This study will involve a single 60-minute visit where eligible participants will undergo an instrumental swallowing evaluation (videofluoroscopy). All women under the age of 62 will be asked to complete a pregnancy test as part of the screening process prior to radiation exposure. The entire duration of the exam will be under 60 minutes and the participant will be free to leave at any point during the examination.
Respiratory, thoracic and mediastinal disorders
Dyspnea
2.9%
1/34 • Number of events 1 • 12 months
Other (adverse event reporting): adverse events related to voluntary and reflex cough testing were collected during the single testing session. Participants were briefly monitored after testing and study was completed following their single visit.
0.00%
0/12 • 12 months
Other (adverse event reporting): adverse events related to voluntary and reflex cough testing were collected during the single testing session. Participants were briefly monitored after testing and study was completed following their single visit.

Additional Information

Lauren Tabor Gray

Holy Cross Hospital

Phone: 954 542 3429

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place